Spironolactone Tablet
Product Images NDC 63629-1064

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
This appears to be a table containing various medical parameters such as subgroup, diabetes, creatinine level, potassium level and beta-blocker medication. The table also seems to include a line chart where Spironolactone is compared to Placebo. However, without more context, it is difficult to provide a more detailed description.*
FDA Label Image

Lbl636291064

Lbl636291064
This is a description of a drug named NILD, which comes in tablet form (30 tablets per unit). Each tablet contains 25mg of Spironolactone USP. It is important to keep this medication and all other drugs out of the reach of children. The recommended storage temperature range is 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F) as defined by the USP (United States Pharmacopeia) controlled room temperature. The medication should be dispensed in a tightly-sealed, light-resistant container as defined by the USP. The drug is available by prescription only (Rx only). The NDC (National Drug Code) number for this drug product is 63629-1064-1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.